Shares of Signet Jewelers (NYSE: SIG) were taking a dive after the company gave a disappointing update to the key holiday quarter and cut its forecast for the fourth quarter. The 10 stocks that made t...
(Reuters) -Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street estimates, marking the second time sales have disappointed sinc...
CEO Mark Zuckerberg has also warned employees about more such job cuts this year to "raise the bar" on performance management, the spokesperson said. Meta has also poured billions into AI-related infr...
Eli Lilly revises Q4 revenue down on slower U.S. incretin market growth, eyes robust 2025 projections...
Structure Therapeutics CEO Raymond Stevens discusses obesity drugs and the company's expansion plans with Katie Greifeld at the JPMorgan Health-Care Conference in San Francisco....
Shares of Eli Lilly (LLY) tumbled intraday Tuesday after the drugmaker lowered fourth-quarter and fu...
Executives at Amgen made the case for MariTide's differentiation, while Merck's CEO contended that Keytruda's coming loss of exclusivity can be managed....